Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2006 1
2010 2
2020 4
2021 1
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: imai t. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab.
Ikegawa S, Meguri Y, Mizuhara K, Fukumi T, Kobayashi H, Sumii Y, Kondo T, Sando Y, Iwamoto M, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Fujisawa Y, Imai T, Maeda Y, Matsuoka KI. Ikegawa S, et al. Among authors: imai t. Leukemia. 2021 Mar;35(3):929-931. doi: 10.1038/s41375-021-01167-8. Epub 2021 Feb 17. Leukemia. 2021. PMID: 33597730 No abstract available.
Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group.
Fujiwara Y, Urata T, Niiya D, Yano T, Nawa Y, Yoshida I, Imai T, Sunami K, Fujii S, Ennishi D, Maeda Y, Hiramatsu Y. Fujiwara Y, et al. Among authors: imai t. Int J Hematol. 2022 Jun;115(6):811-815. doi: 10.1007/s12185-022-03363-3. Epub 2022 May 18. Int J Hematol. 2022. PMID: 35583725
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.
Shimazu Y, Kanda J, Suzuki K, Wada A, Kikuchi T, Ikeda T, Tsukada N, Miwa A, Itagaki M, Kako S, Nishiwaki K, Ota S, Fujiwara SI, Kataoka K, Doki N, Sawa M, Hiramoto N, Nishikawa A, Imai T, Ichinohe T, Kanda Y, Atsuta Y, Kawamura K. Shimazu Y, et al. Among authors: imai t. Cancer Sci. 2024 May 16. doi: 10.1111/cas.16198. Online ahead of print. Cancer Sci. 2024. PMID: 38757410 Free article.
18 results